[1]
|
Riggio, A.I., Varley, K.E. and Welm, A.L. (2021) The Lingering Mysteries of Metastatic Recurrence in Breast Cancer. British Journal of Cancer, 124, 13-26. https://www.nature.com/articles/s41416-020-01161-4
|
[2]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Esti-mates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[3]
|
Ghoncheh, M., Pournamdar, Z. and Salehiniya, H. (2016) Inci-dence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pacific Journal of Cancer Prevention, 17, 43-46. https://doi.org/10.7314/APJCP.2016.17.S3.43
|
[4]
|
Yersal, O. and Barutca, S. (2014) Biological Subtypes of Breast Cancer: Prognostic and Therapeutic Implications. World Journal of Clinical Oncology, 5, 412-424. https://doi.org/10.5306/wjco.v5.i3.412
|
[5]
|
Arpino, G., Generali, D., Sapino, A., et al. (2013) Gene Expression Profiling in Breast Cancer: A Clinical Perspective. The Breast, 22, 109-120. https://doi.org/10.1016/j.breast.2013.01.016
|
[6]
|
Eliyatkin, N., Yalcin, E., Zengel, B., Aktaş, S. and Vardar, E. (2018) Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to a New Age, and a New Way. Journal of Breast Health, 11, 59-66.
|
[7]
|
Anders, C. and Carey, L.A. (2008) Understanding and Treating Tri-ple-Negative Breast Cancer. Oncology (Williston Park), 22, 1233-1239.
|
[8]
|
Hubalek, M., Czech, T. and Müller, H. (2017) Biological Subtypes of Triple-Negative Breast Cancer. Breast Care (Basel), 12, 8-14. https://doi.org/10.1159/000455820
|
[9]
|
Carey, L.A., Perou, C.M., Livasy, C.A., et al. (2006) Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-2502. https://doi.org/10.1001/jama.295.21.2492
|
[10]
|
Fiorica, J.V. (2016) Breast Cancer Screening, Mammography, and other Modalities. Clinical Obstetrics and Gynecology, 59, 688-709. https://doi.org/10.1097/GRF.0000000000000246
|
[11]
|
Jochelson, M. (2012) Advanced Imaging Techniques for the Detection of Breast Cancer. American Society of Clinical Oncology Educational Book, 32, 65-69. https://doi.org/10.14694/EdBook_AM.2012.32.223
|
[12]
|
Dodelzon, K., Simon, K., Dou, E., Levy, A.D., Michaels, A.Y., Askin, G. and Katzen, J.T. (2020) Performance of 2D Synthetic Mammography versus Digital Mammography in the Detection of Microcalcifications at Screening. AJR. American Journal of Roentgenology, 214, 1436-1444. https://doi.org/10.2214/AJR.19.21598
|
[13]
|
Clauser, P., Nagl, G., Helbich, T.H., Pinker-Domenig, K., Weber, M., Kapetas, P., Bernathova, M. and Baltzer, P.A.T. (2016) Diagnostic Performance of Digital Breast Tomosynthesis with a Wide Scan Angle Compared to Full-Field Digital Mammography for the Detection and Characterization of Microcalcifi-cations. European Journal of Radiology, 85, 2161-2168. https://doi.org/10.1016/j.ejrad.2016.10.004
|
[14]
|
Hofvind, S., Holen, Å.S., Aase, H.S., Houssami, N., Sebuødegård, S., Moger, T.A., Haldorsen, I.S. and Akslen, L.A. (2019) Two-View Digital Breast Tomosynthesis versus Digital Mammography in a Population-Based Breast Cancer Screening Programme (To-Be): A Randomised, Controlled Trial. The Lancet Oncology, 20, 795-805.
https://doi.org/10.1016/S1470-2045(19)30161-5
|
[15]
|
Haka, A.S., Shafer-Peltier, K.E., Fitzmaurice, M., Crowe, J., Dasari, R.R. and Feld, M.S. (2002) Identifying Microcalcifications in Benign and Malignant Breast Lesions by Probing Differences in Their Chemical Composition Using Raman Spectroscopy. Cancer Research, 62, 5375-5380.
|
[16]
|
Tabár, L., Chen, H.-H., Duffy, S.W., Yen, M.F., Chiang, C.F., Dean, P.B., et al. (2000) A Novel Method for Prediction of Long-Term Outcome of Women with T1a, T1b, and 10-14 mm Invasive Breast Cancers: A Prospective Study. The Lan-cet, 355, 429-433. https://doi.org/10.1016/S0140-6736(00)82008-5
|
[17]
|
Ling, H., Liu, Z.-B., Xu, L.-H., Xu, X.-L., Liu, G.-Y. and Shao, Z.-M. (2013) Malignant Calcification Is an Important Unfavorable Prognostic Factor in Primary Invasive Breast Cancer. Asia-Pacific Journal of Clinical Oncology, 9, 139-145. https://doi.org/10.1111/j.1743-7563.2012.01572.x
|
[18]
|
O’Grady, S. and Morgan, M.P. (2018) Microcalcifications in Breast Cancer: From Pathophysiology to Diagnosis and Prognosis. Biochimica et Biophysica Acta—Reviews on Can-cer, 1869, 310-320.
https://doi.org/10.1016/j.bbcan.2018.04.006
|
[19]
|
Li, J.-J., Chen, C., Gu, Y., Di, G., Wu, J., Liu, G., et al. (2014) The Role of Mammographic Calcification in the Neoadjuvant Therapy of Breast Cancer Imaging Evaluation. PLOS ONE, 9, e88853.
https://doi.org/10.1371/journal.pone.0088853
|
[20]
|
Murata, A., Sannomiya, N., Miyamoto, N., Ueda, N., Kamida, A., Koyanagi, Y., et al. (2015) Microcalcification of Tumor Is a Predictor of Response to Neoadjuvant Chemotherapy for Invasive Breast Carcinoma. Yonago Acta Medica, 58, 85-88.
|
[21]
|
Nakashoji, A., Matsui, A., Nagayama, A., Iwata, Y., Sasahara, M. and Murata, Y. (2017) Clinical Predictors of Pathological Complete Response to Neoadjuvant Chemother-apy in Triple-Negative Breast Cancer. Oncology Letters, 14, 4135-4141. https://doi.org/10.3892/ol.2017.6692
|
[22]
|
DiCorpo, D., Tiwari, A., Tang, R., Griffin, M., Aftreth, O., Bautista, P., Hughes, K., Gershenfeld, N. and Michaelson, J. (2020) The Role of Micro-CT in Imaging Breast Cancer Specimens. Breast Cancer Research Treatment, 180, 343-357.
https://doi.org/10.1007/s10549-020-05547-z
|
[23]
|
Xu, J., Li, F. and Chang, F. (2017) Correlation of the Ultrasound Imaging of Breast Cancer and the Expression of Molecular Biological Indexes. Pakistan Journal of Pharmaceutical Sci-ences, 30, 1425-1430.
|
[24]
|
Shin, H.J., Kim, H.H., Huh, M.O., et al. (2011) Correlation between Mammographic and Sonographic Findings and Prognostic Factors in Patients with Node-Negative Invasive Breast Cancer. The British Jour-nal of Radiology, 84, 19-30.
https://doi.org/10.1259/bjr/92960562
|
[25]
|
Choi, W.J., Sim, H., Kim, H.J., Cha, J.H., Shin, H.J., Chae, E.Y. and Kim, H.H. (2021) Association of Mammography and Ultrasound Features with MammaPrint in Patients with Estrogen Receptor-Positive, HER2-Negative, Node-Positive Invasive Breast Cancer. Acta Radiologica, 62, 1592-1600. https://doi.org/10.1177/0284185120980003
|
[26]
|
Lehman, C.D., Isaacs, C., Schnall, M.D., et al. (2007) Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study. Radiology, 244, 381-388.
https://doi.org/10.1148/radiol.2442060461
|
[27]
|
Saslow, D., Boetes, C., Burke, W., et al. (2007) American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography. CA: A Cancer Journal for Clinicians, 57, 75-89. https://doi.org/10.3322/canjclin.57.2.75
|
[28]
|
Choi, E.J., Choi, H., Choi, S.A. and Youk, J.H. (2016) Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging for the Prediction of Early and Late Recurrences in Breast Cancer. Medicine (Baltimore), 95, e5330.
https://doi.org/10.1097/MD.0000000000005330
|
[29]
|
Cheon, H., Kim, H.J., Kim, T.H., Ryeom, H.K., Lee, J., Kim, G., Yuk, J.S. and Kim, W.H. (2018) Invasive Breast Cancer: Prognostic Value of Peritumoral Edema Identified at Pre-operative MR Imaging. Radiology, 287, 68-75.
https://doi.org/10.1148/radiol.2017171157
|
[30]
|
Costantini, M., Belli, P., Distefano, D., et al. (2012) Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison with Luminal and HER2-Overexpressing Tumors. Clinical Breast Cancer, 12, 331-339.
https://doi.org/10.1016/j.clbc.2012.07.002
|
[31]
|
Navarro, V.L., Alandete, G.S.P., Medina García, R., Blanc García, E., Camarasa Lillo, N. and Vilar Samper, J. (2017) MR Imaging Findings in Molecular Subtypes of Breast Cancer Ac-cording to BIRADS System. The Breast Journal, 23, 421-428. https://doi.org/10.1111/tbj.12756
|
[32]
|
Kawashima, H., Miyati, T., Ohno, N., Ohno, M., Inokuchi, M., lkeda, H. and Gabata, T. (2017) Differentiation between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Academic Radiology, 24, 1575-1581. https://doi.org/10.1016/j.acra.2017.06.016
|
[33]
|
Shin, J.K. and Kim, J.Y. (2017) Dynamic Contrast-Enhanced and Diffusion-Weighted MRI of Estrogen Receptor-Positive Invasive Breast Cancers: Associations between Quantitative MR Parameters and Ki-67 Proliferation Status. Journal of Magnetic Reso-nance Imaging, 45, 94-102. https://doi.org/10.1002/jmri.25348
|
[34]
|
Kim, E.J., Kim, S.H., Park, G.E., Kang, B.J., Song, B.J., Kim, Y.J., Lee, D., Ahn, H., Kim, I., Son, Y.H. and Grimm, R. (2015) Histogram Analysis of Apparent Diffusion Coefficient at 3.0 t: Correlation with Prognostic Factors and Subtypes of Invasive Ductal Carcinoma. Journal of Magnetic Resonance Imaging, 42, 1666-1678.
https://doi.org/10.1002/jmri.24934
|
[35]
|
Baxter, G.C., Graves, M.J., Gilbert, F.J. and Patterson, A.J. (2019) A Me-ta-Analysis of the Diagnostic Performance of Diffusion MRI for Breast Lesion Characterization. Radiology, 291, 632-641.
https://doi.org/10.1148/radiol.2019182510
|
[36]
|
Onaygil, C., Kaya, H., Ugurlu, M.U. and Aribal, E. (2017) Diag-nostic Performance of Diffusion Tensor Imaging Parameters in Breast Cancer and Correlation with the Prognostic Fac-tors. Journal of Magnetic Resonance Imaging, 45, 660-672. https://doi.org/10.1002/jmri.25481
|
[37]
|
Zhang, L., Tang, M., Min, Z., Lu, J., Lei, X. and Zhang, X. (2016) Accuracy of Combined Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging for Breast Cancer Detection: A Meta-Analysis. Acta Radiologica, 57, 651-660. https://doi.org/10.1177/0284185115597265
|
[38]
|
Baltzer, P.A., Schafer, A., Dietzel, M., Grassel, D., Gajda, M., Camara, O., et al. (2011) Diffusion Tensor Magnetic Resonance Imaging of the Breast: A Pilot Study. Euro-pean Radiology, 21, 1-10.
https://doi.org/10.1007/s00330-010-1901-9
|
[39]
|
Teruel, J.R., Goa, P.E., Sjobakk, T.E., Ostlie, A., Fjosne, H.E. and Bathen, T.F. (2016) Diffusion Weighted Imaging for the Differentiation of Breast Tumors: From Apparent Diffusion Coefficient to High Order Diffusion Tensor Imaging. Journal of Magnetic Resonance Imaging, 43, 1111-1121. https://doi.org/10.1002/jmri.25067
|
[40]
|
Partridge, S.C., Ziadloo, A., Murthy, R., White, S.W., Peacock, S., Eby, P.R., et al. (2010) Diffusion Tensor MRI: Preliminary Anisotropy Measures and Mapping of Breast Tumors. Journal of Magnetic Resonance Imaging, 31, 339-347.
https://doi.org/10.1002/jmri.22045
|
[41]
|
Cakir, O., Arslan, A., Inan, N., Anik, Y., Sarisoy, T., Gumustas, S., et al. (2013) Comparison of the Diagnostic Performances of Diffusion Parameters in Diffusion Weighted Imaging and Diffu-sion Tensor Imaging of Breast Lesions. European Journal of Radiology, 82, e801-e806. https://doi.org/10.1016/j.ejrad.2013.09.001
|
[42]
|
Eyal, E., Shapiro-Feinberg, M., Furman-Haran, E., Grobgeld, D., Golan, T., Itzchak, Y., et al. (2012) Parametric Diffusion Tensor Imaging of the Breast. Investigative Radiology, 47, 284-291.
https://doi.org/10.1097/RLI.0b013e3182438e5d
|
[43]
|
Yamaguchi, K., Nakazono, T., Egashira, R., Komori, Y., Nakamura, J., Noguchi, T., et al. (2017) Diagnostic Performance of Diffusion Tensor Imaging with Readout-Segmented Echo-Planar Imaging for Invasive Breast Cancer: Correlation of ADC and FA with Pathological Prognostic Markers. Magnetic Resonance in Medical Sciences, 16, 245-252.
https://doi.org/10.2463/mrms.mp.2016-0037
|
[44]
|
Kim, J.Y., Kim, J.J., Kim, S., Choo, K.S., Kim, A., Kang, T., et al. (2018) Diffusion Tensor Magnetic Resonance Imaging of Breast Cancer: Associations between Diffusion Metrics and Histological Prognostic Factors. European Radiology, 28, 3185-3193. https://doi.org/10.1007/s00330-018-5429-8
|
[45]
|
Kvistad, K.A., Bakken, L.J., Gribbestad, I.S., et al. (1999) Char-acterization of Neoplastic and Normal Human Breast Tissues with in Vivo (1) HMR Spectroscopy. Journal of Magnetic Resonance Imaging, 10, 159-164.
https://doi.org/10.1002/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0
|
[46]
|
Cecil, K.M., Schnall, M.D., Siegelman, E.S. and Lenkinski, R.E. (2001) The Evaluation of Human Breast Lesions with Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy. Breast Cancer Research and Treatment, 68, 4554. https://doi.org/10.1023/A:1017911211090
|
[47]
|
Bolan, P.J. (2013) Magnetic Resonance Spectroscopy of the Breast: Current Status. Magnetic Resonance Imaging Clinics of North America, 21, 625-639. https://doi.org/10.1016/j.mric.2013.04.008
|
[48]
|
Tozaki, M., Sakamoto, M., Oyama, Y., Maruyama, K. and Fukuma, E. (2010) Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer with Quantitative 1H MR Spectroscopy Using the External Standard Method. Journal of Magnetic Resonance Imaging, 31, 895-902. https://doi.org/10.1002/jmri.22118
|
[49]
|
Jacobs, M.A., Stearns, V., Wolff, A.C., et al. (2010) Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear ((2)(3)Na) Imaging Monitoring of Preoperative Chemo-therapy for Locally Advanced Breast Cancer. Academic Radiology, 17, 1477-1485. https://doi.org/10.1016/j.acra.2010.07.009
|
[50]
|
Shin, H.J., Baek, H.M., Ahn, J.H., et al. (2012) Prediction of Path-ologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer Using Diffusion-Weighted Imaging and MRS. NMR in Biomedicine, 25, 1349-1359.
https://doi.org/10.1002/nbm.2807
|
[51]
|
Kajáry, K., Tőkés, T., Dank, M., Kulka, J., Szakáll, S. and Lengyel, Z. (2015) Correlation of the Value of 18F-FDG Uptake, Described by SUVmax, SUVavg, Metabolic Tumour Volume and Total Lesion Glycolysis, to Clinicopathological Prognostic Factors and Biological Subtypes in Breast Cancer. Nuclear Medicine Communications, 36, 28-37.
https://doi.org/10.1097/MNM.0000000000000217
|
[52]
|
Kaida, H., Toh, U., Hayakawa, M., Hattori, S., Fujii, T., Kurata, S., Kawa-hara, A., Hirose, Y., Kage, M. and Ishibashi, M. (2013) The Relationship between 18F-FDG Metabolic Volumetric Parameters and Clinicopathological Factors of Breast Cancer. Nuclear Medicine Communications, 34, 562-570. https://doi.org/10.1097/MNM.0b013e328360d945
|
[53]
|
Tchou, J., Sonnad, S.S., Bergey, M.R., Basu, S., Tomaszewski, J., Alavi, A. and Schnall, M. (2010) Degree of Tumor FDG Uptake Correlates with Proliferation Index in Triple Negative Breast Cancer. Molecular Imaging and Biology, 12, 657-662. https://doi.org/10.1007/s11307-009-0294-0
|
[54]
|
Tőkés, T., Somlai, K., Székely, B., Kulka, J., Szentmártoni, G., Torgyík, L., Galgóczy, H., Lengyel, Z., Györke, T. and Dank, M. (2012) The Role of FDG-PET-CT in the Evaluation of Primary Systemic Therapy in Breast Cancer: Links between Metabolic and Pathological Remission. Orvosi Hetilap, 153, 1958-1964.
https://doi.org/10.1556/OH.2012.29495
|
[55]
|
Jiménez-Ballvé, A., García García-Esquinas, M., Salsidua-Arroyo, O., Serrano-Palacio, A., García-Sáenz, J.A., Ortega Candil, A., Fuentes Ferrer, M.E., Rodríguez Rey, C., Román-Santamaría, J.M., Moreno, F. and Carreras-Delgado, J.L. (2016) Prognostic Value of Metabolic Tumour Volume and Total Lesion Glycolysis in 18F-FDG PET/CT Scans in Locally Advanced Breast Cancer Staging. Revista Española de Medicina Nu-clear e Imagen Molecular, 35, 365-372.
https://doi.org/10.1016/j.remnie.2016.09.001
|
[56]
|
Groheux, D., Martineau, A., Teixeira, L., Espié, M., de Cremoux, P., Bertheau, P., Merlet, P. and Lemarignier, C. (2017) 18FDG-PET/CT for Predicting the Outcome in ER+/HER2-Breast Cancer Patients: Comparison of Clinicopathological Parameters and PET Image-Derived Indices In-cluding Tumor Texture Analysis. Breast Cancer Research, 19, Article No. 3. https://doi.org/10.1186/s13058-016-0793-2
|